Premier Biomedical, Inc.

BIEI

US74048K2033

Specialty Chemicals

Market Closed - OTC Markets Other stock markets 12:50:25 15/06/2024 am IST			5-day change	1st Jan Change
0.001 ^USD	+11.11%		+11.11%	+11.11%

07/03	Premier Graphene, Inc. Appoints Gustavo Carreño as Chief Technology Officer	CI
2022	Nova-Graphene Ballistics, Inc. Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production Methodology	CI

Premier Biomedical, Inc. Adds Dr. James Frincke to Scientific Advisory Board

August 19, 2015 at 05:30 pm IST

Premier Biomedical, Inc. announced the addition of Dr. James Frincke to their Scientific Advisory Board effective immediately. Dr. Frincke will report to co-founder and Chairman of the Scientific Advisory Board, Dr. Mitchell S. Felder, MD, and to the President and CEO, William A. Hartman.
James Frincke, PhD, is a Research & Development Consultant at Red Spot Biosciences, LLC, currently providing pro bono consultation to physicians globally to discover treatments for diseases, such as Crohn's, Rheumatoid Arthritis, Alzheimer's, Parkinson's and Type 1 Diabetes.

Latest news about Premier Biomedical, Inc.

Premier Graphene, Inc. Appoints Gustavo Carreño as Chief Technology Officer	08/03	CI
Nova-Graphene Ballistics, Inc. Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production Methodology	21/22/21	CI
Itaú Unibanco S A : Brazilian billionaire Lemann leads initiative to build COVID-19 vaccine factory	08/20/08	RE
William A. Hartman Resigns as Chief Executive Officer of Premier Biomedical, Inc	02/20/02	CI
Heidi H. Carl Resigns as Chief Financial Officer of Premier Biomedical, Inc	02/20/02	CI
Premier Biomedical, Inc. Announces Executive Changes	02/20/02	CI
Premier Biomedical, Inc. Appoints David Caplan to the Board of Directors	01/20/01	CI
Premier Biomedical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	16/20/16	CI
Premier Biomedical, Inc. Announces Resignation of Mitchell Felder as Chairman and Member of Board of Directors	07/20/07	CI
Premier Biomedical, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	15/19/15	CI
Premier Biomedical, Inc. announced that it has received $0.025 million in funding from Green Coast Capital International S.A.	03/19/03	CI
Premier Biomedical, Inc. announced that it expects to receive $5 million in funding from Green Coast Capital International S.A.	26/19/26	CI
Premier Biomedical, Inc. announced that it has received $0.043 million in funding from PowerUp Lending Group, Ltd.	16/19/16	CI
Premier Biomedical, Inc. announced that it expects to receive $0.043 million in funding from PowerUp Lending Group, Ltd.	15/19/15	CI
Premier Biomedical, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	15/19/15	CI
Premier Biomedical, Inc. announced that it has received $0.038 million in funding from PowerUp Lending Group, Ltd.	07/19/07	CI
Premier Biomedical, Inc. Announces Joint Venture with New Earth Development Corporation, Rushnet, Inc., and XYZ Hemp, Inc	06/19/06	CI
Premier Biomedical, Inc. announced that it expects to receive $0.038 million in funding from PowerUp Lending Group, Ltd.	02/19/02	CI
Premier Biomedical, Inc. Announces Signing of an Agreement Forming a Joint Venture with New Earth Development Corporation, RushNet, Inc., and XYZ Hemp, Inc	30/19/30	CI
Premier Biomedical, Inc. announced that it has received $0.038 million in funding from PowerUp Lending Group, Ltd.	12/19/12	CI
Premier Biomedical, Inc. announced that it expects to receive $0.038 million in funding from PowerUp Lending Group, Ltd.	07/19/07	CI
Premier Biomedical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	16/19/16	CI
Premier Biomedical, Inc. announced that it has received $0.038 million in funding from PowerUp Lending Group, Ltd.	23/19/23	CI
Premier Biomedical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	16/19/16	CI
Premier Biomedical, Inc. announced that it has received $0.068 million in funding from PowerUp Lending Group, Ltd.	28/19/28	CI

Chart Premier Biomedical, Inc.

Duration

Period

More charts

Company Profile

Premier Graphene, Inc. is a global advanced materials firm with a focus on research, production and marketing of eco-friendly graphene. The Companyâs graphene and novel additive formulations are integrated into the production process of other products. The Company is engaged in supplying large-scale industrial quantities. Its proprietary graphene blends and formulations target specific product enhancements sought by manufacturers.

Sector

Specialty Chemicals

More about the company

Sector Other Specialty Chemicals

	1st Jan change	Capi.
PREMIER BIOMEDICAL, INC.	+11.11%	10.99L
ECOLAB INC.	+21.02%	6.86TCr
SIKA AG	-6.50%	4.61TCr
GIVAUDAN SA	+23.31%	4.45TCr
FUJIFILM HOLDINGS CORPORATION	+31.85%	2.85TCr
EMS-CHEMIE HOLDING AG	+7.56%	1.92TCr
POSCO FUTURE M CO., LTD.	-23.96%	1.53TCr
CELANESE CORPORATION	-10.29%	1.52TCr
ALBEMARLE CORPORATION	-28.36%	1.22TCr
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-29.56%	1.21TCr

Other Specialty Chemicals